Stockreport

Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

Reviva Pharmaceuticals Holdings, Inc.  (RVPH) 
PDF CUPERTINO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical comp [Read more]